W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All longevity clinics diagnostics longevity-clinic-comparison clinics longevity-diagnostics regulation best-longevity-clinics biomarkers clinic comparison evidence evidence-based healthspan industry-news longevity longevity-treatments medical tourism aging research biohacking clinical-trials clinique-la-prairie fountain-life longevity-clinics longevity-industry longevity-science NAD-therapy peptide-therapy preventive-health progevita aging aging-research biological-age BPC-157 business cleveland-clinic clinic-comparison clinical trials epigenetic-clock executive health FDA-regulation hospital-longevity-programs innovation lanserhof longevity clinic cost longevity treatments longevity-medicine longevity-medicine-europe NMN NR plasmapheresis preventive medicine research sha-wellness-clinic stem cell therapy stem cells US-longevity-clinics affordable-longevity-europe aging frailty AI diagnostics AI-drug-discovery ai-medicine allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-usa biograph biological age reversal biomarker-testing blood-filtering-therapy buchinger-wilhelmi cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo editorial EMA epigenetics european longevity clinics european-longevity-clinics european-wellness evidence-based-medicine executive health program cost executive physical cost executive-health franchises full-body MRI genomics geroscience health assessment Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan longevity clinic longevity clinic europe longevity clinic regulation longevity health assessment longevity medicine longevity-clinic-cost longevity-clinic-europe longevity-clinic-guide longevity-clinics-expansion longevity-expansion longevity-medical-tourism longevity-ranking longevity-technology longevity-testing longevity-tourism luxury-longevity luxury-wellness-europe marketing mayo-clinic media men health MSC therapy mTOR inhibitors multiomics NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi patient guide patient safety peptide therapy peptides performance pharmaceutical-industry prevention privacy Progevita programs proteomics protocols rapamycin regenerative regenerative medicine regenerative-medicine regulatory-policy risk Saudi-Arabia screening senolytics SHA Wellness Spain sports medicine startups TGF-beta therapeutic plasma exchange therapeutic-fasting TPE treatment-comparison treatments United States UT Health San Antonio VO2-max Ways2Well wellness
UT Health San Antonio Peer-reviewed

Rapamycin Goes Mainstream: UT Health San Antonio Launches Large-Scale Clinical Trial

UT Health San Antonio launches a National Institute on Aging-funded rapamycin trial with 84 older adults—one of the largest longevity-focused clinical studies to date. The shift: from off-label speculation to evidence-based dosing.

rapamycin mTOR inhibitors clinical trials
PR Newswire

Human Longevity Inc. and LEV Foundation Team Up to Decode Why Centenarians Age Differently

Human Longevity Inc. partners with LEV Foundation to study blood from centenarians and supercentenarians using multi-omic analysis — seeking biomarkers that explain why some people age far more slowly.

Human Longevity centenarians biomarkers
ARPA-H Peer-reviewed

ARPA-H Commits $144 Million to the First Clinical Trials Designed to Extend Healthspan

The U.S. government's ARPA-H launches the PROSPR program: $144M over five years to identify early aging biomarkers and run the first clinical trials explicitly aimed at extending healthy lifespan.

ARPA-H healthspan clinical trials